Erste Asset Management’s Harmony Biosciences HRMY Stock Holding History

Erste Asset Management’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$463K	Hold	13,100	–	–	﹤0.01%	521
2026 Q1	$352K	Hold	13,100	–	–	﹤0.01%	537
2025 Q4	$497K	Hold	13,100	–	–	﹤0.01%	497
2025 Q3	$362K	Hold	13,100	–	–	﹤0.01%	514
2025 Q2	$419K	Hold	13,100	–	–	﹤0.01%	656
2025 Q1	$435K	Hold	13,100	–	–	0.01%	438
2024 Q4	$448K	Hold	13,100	–	–	0.01%	446
2024 Q3	$513K	Hold	13,100	–	–	0.01%	435
2024 Q2	$412K	Hold	13,100	–	–	0.01%	431
2024 Q1	$439K	Hold	13,100	–	–	0.01%	436
2023 Q4	$437K	Hold	13,100	–	–	0.01%	438
2023 Q3	$450K	Hold	13,100	–	–	0.01%	417
2023 Q2	$463K	Hold	13,100	–	–	0.01%	420
2023 Q1	$428K	Hold	13,100	–	–	0.01%	437
2022 Q4	$723K	Hold	13,100	–	–	0.02%	393
2022 Q3	$572K	Hold	13,100	–	–	0.01%	404
2022 Q2	$661K	Hold	13,100	–	–	0.01%	397
2022 Q1	$653K	Buy	+13,100	New	+$534K	0.01%	410

Other funds holding HRMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Erste Asset Management's HRMY Position: Q2 2026 in Review

Erste Asset Management held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 13,100 shares worth $463K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Erste Asset Management first reported a position in HRMY in Q1 2022 and has held it in 18 quarters since. The position peaked at $723K in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

Erste Asset Management held 13,100 shares of Harmony Biosciences worth $463K as of Q2 2026.
Erste Asset Management left its Harmony Biosciences share count unchanged in Q2 2026.
Harmony Biosciences made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #521 holding.
Erste Asset Management first reported a position in Harmony Biosciences in Q1 2022 and has held it in 18 quarters since.
Erste Asset Management's Harmony Biosciences position peaked at $723K in Q4 2022.
327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.